Previous close | 72.25 |
Open | 72.99 |
Bid | 74.24 x 900 |
Ask | 74.27 x 1400 |
Day's range | 72.34 - 75.14 |
52-week range | 60.83 - 81.42 |
Volume | |
Avg. volume | 3,218,160 |
Market cap | 39.667B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 14.66 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Wellcare, the Medicare business of Centene Corporation (NYSE: CNC), and Wellvana, a value-based care physician enablement company, today announced a multi-year partnership that seeks to expand affordable, patient-centered primary healthcare to thousands of Wellcare Medicare Advantage members in Georgia, Tennessee and Texas. The partnership will support independent primary care physicians involved in valued-based care in those states to improve clinical outcomes for Wellcare's Medicare Advantage
Centene Corporation (NYSE: CNC) ("the Company") announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 first quarter results were as follows:
Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Meridian in Michigan (Meridian), has been selected by the Michigan Department of Health and Human Services (MDHHS) to continue to serve as a Medicaid health plan for the Comprehensive Health Care Program, which serves nearly 2 million Michiganders statewide. The proposed Medicaid contracts are expected to begin on October 1, 2024, and run through